Jabra Enhance Select 300 vs Lexie B3

The Jabra Enhance Select 300 is a premium OTC hearing aid priced at $1,695 that earns an A grade with a SoundScore of 4.1/5 in our lab testing. This behind-the-ear device ranks #17 out of 65 OTC hearing aids tested, placing it in the top 25% of its category. In our standardized testing, speech clarity in quiet environments stands out as a notable strength, scoring 3.6/5—a solid result that sits 0.85 points above the category average. Feedback handling is excellent at 5.0/5, meaning users should experience stable performance without whistling during typical wear. Own-voice comfort also performs well at 3.5/5, nearly a full point above average, which can contribute to a more natural listening experience. Speech understanding in noisy environments presents a limitation, scoring 1.5/5—essentially at the category average but low in absolute terms. This is a common challenge across OTC devices, though users seeking strong noise performance may want to compare alternatives. Music streaming scores 2.6/5, which is above the category average by 0.68 points but mixed in absolute quality. The Enhance Select 300 offers rechargeable batteries and streaming compatibility with both iPhone and Android devices, along with hands-free functionality. It has earned Expert's Choice Awards in both 2023 and 2024. Shoppers in this price range should note that alternatives like the Lucid Tala and Audicus Omni 2 score higher overall, while options like the Jabra Enhance Pro 20 at Costco offer similar sound quality at a lower price point. This device is best suited for those prioritizing speech clarity in quieter settings and stable, feedback-free performance.

The Lexie B3 is a behind-the-ear OTC hearing aid priced at $999 that earns an A grade with a SoundScore of 4.8/5 in our lab testing. This places it at #1 among the 65 OTC hearing aids we've evaluated, making it a standout performer in its category. In our standardized testing, the Lexie B3 demonstrates excellent speech-in-quiet performance at 4.5/5, scoring 1.73 points above the OTC category average of 2.79/5. Speech-in-noise results are more nuanced—while the 2.5/5 score sits 1.02 points above the category average of 1.48/5, this remains mixed in absolute terms. Music streaming quality is solid at 3.3/5, exceeding the category average by 1.38 points, and feedback handling is excellent at 4.6/5. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above the category average. The device uses a tulip dome coupling in both initial and tuned configurations, maintaining consistent performance across fitting conditions with identical normalized scores of 4.8/5 for both fits. For those considering alternatives, devices like the RxEars Rxi, Meta Ray-Ban Glasses (Gen 2), and Cearvol Wave offer lower price points, though with correspondingly lower SoundScores. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance who prioritize speech clarity in quieter environments and quality music streaming, and who can accommodate its mid-tier OTC price point.